November 15, 2012

Acura Pharmaceuticals in December will launch an immediate-release pseudoephedrine tablet under the brand name Nexafed that will help impede conversion of the tablets into methamphetamine.

November 8, 2012

Business for OTC store brands is expected to boom in the coming year, Perrigo chairman and CEO Joseph Papa told analysts discussing the private-label manufacturer's first quarter results during a conference call Wednesday, even as the growth rate across the entire OTC category slows.

November 7, 2012

A recent University of Cincinnati study suggested adolescent males are at a higher risk of reporting longtime abuse of over-the-counter drugs, compared with their female peers.

October 31, 2012

Watson Pharmaceuticals on Wednesday announced the sale of its Rugby over-the-counter business to the Harvard Drug Group — a distributor and provider of private-label OTCs and generic prescription products under the Major Pharmaceuticals brand — for approximately $117 million.

October 16, 2012

Perrigo has received tentative approval from the U.S. Food and Drug Administration for its abbreviated new drug application to market over-the-counter omeprazole and sodium bicarbonate capsules in the 20-mg/1,100-mg strength, the store-brand equivalent to Merck's Zegerid OTC.

October 9, 2012

Summit Laboratories recently launched a pair of skin care items ideal for people with diabetes. Aside from kidney and eye disorders, skin disorders are one of the top challenges for diabetics.

October 1, 2012

The Community Anti-Drug Coalitions of America and the Consumer Healthcare Products Association are mobilizing communities to stop prescription and over-the-counter medicine abuse during National Medicine Abuse Awareness Month, the groups announced Monday.

September 27, 2012

Satisfaction among customers using mail-order pharmacies to fill their prescriptions continued to decline, falling significantly below customer satisfaction with brick-and-mortar pharmacies, according to the J.D. Power and Associates "2012 U.S. Pharmacy Study" released Thursday.

September 24, 2012

As part of CVS Caremark's sponsorship of The Partnership at Drugfree.org's The Medicine Abuse Project, which aims to prevent a half-million teens from abusing medicine over the next five years, the company now is asking its customers to take the project's pledge to learn about teen medicine abuse, to safeguard medicines in the home and to talk to teens about this issue, the company announced on Monday.

September 20, 2012

The Senate on Wednesday passed a resolution naming October as National Medicine Abuse Awareness Month.

September 12, 2012

Most advertisements for over-the-counter versions of drugs did contain significantly less information about the risks of the medication, compared with the ads for the drug prior to its transition to OTC status, according to new research sponsored by CVS Caremark.

September 6, 2012

CVS Caremark announced that it has joined with a group of public and private sector partners and will sponsor the "The Medicine Abuse Project," a multiyear effort by The Partnership at Drugfree.org to raise awareness and curb the abuse of prescription drugs and over-the-counter medicines.

September 4, 2012

According to a Food and Drug Administration post Friday, the FDA's Nonprescription Drugs Advisory Committee will be meeting Nov. 9 regarding the partial switch application from prescription to over the counter of Oxytrol (oxybutynin transdermal system), as submitted by MSD Consumer.

July 24, 2012

Significant product recalls and the ongoing recession have driven consumer behavior change in the OTC aisle, according to a new report published Tuesday by Kline.

June 28, 2012

A new continuing-education program offered by a national pharmacist professional organization aims to prepare pharmacists to communicate with patients about the safe and effective use of the painkiller acetaminophen.

June 7, 2012

Government authorities are working to educate independent pharmacy owners on prescription drug abuse, an independent pharmacy network said.

May 31, 2012

The House Ways and Means Committee on Thursday approved the Restoring Access to Medication Act (H.R. 5842), which would repeal the provision of the Patient Protection and Affordable Care Act that disqualified expenses for over-the-counter drugs as eligible for reimbursement under health savings accounts and flexible spending arrangements without a prescription.

May 29, 2012

The House of Representatives will vote to repeal limitations on the use of tax-advantaged accounts for the purchase of over-the-counter medications as early as June 4, according to a report published online by The Hill, a Washington, D.C.-based political newspaper.

May 11, 2012

Despite predictions that consumers in recessionary times would flock to cheaper over-the-counter drugs, the world's over-the-counter drug market grew just 3.5% in the past three years, according a report released by Kalorama Information.

May 7, 2012

The National Association of Chain Drug Stores submitted on Monday comments to the Food and Drug Administration regarding its position on the “new paradigm” for a third class of drugs.

April 13, 2012

Get set for another decade of explosive growth throughout the over-the-counter category with the familiar switch as a catalyst. 


April 9, 2012

Investment firm J. Burke Capital Partners has increased its strategic investment into Leading Edge Innovations, a Branchburg, N.J., company that develops cosmetic formulas in skin care, sun care, hair care and other related categories for use in over-the-counter drugs and personal care products.

March 29, 2012

The U.S. over-the-counter drug market saw strong growth in 2011, thanks to switches of prescription drugs to OTC, gains in the allergy relief products category and holistic marketing, according to a new report from Kline.

March 12, 2012

One of the long-term goals of many drug companies has been to win Food and Drug Administration approval for cholesterol-lowering statins as over-the-counter drugs. But it's a goal that has long eluded them due to the agency's concerns about patient safety.